Aiia Launches Challenge To Encourage Early Startups

All India Institute of Ayurveda (AIIA) and the Central Council for Research in Ayurvedic Sciences (CCRAS) jointly organized an Interactive meeting for Research and Education in Ayush with a focus on R& D, Education, and capacity building today at New Delhi. The objective of the interactive meeting was to brainstorm and set goals to capitalize on the expertise and experience of the Chairs in academic and research avenues. The participants discussed the research education ecosystem in Ayush Colleges, at both graduation and post-graduation levels. The meeting was focused on Research & Development, Education & capacity building in the Ayush sector. All the Directors presented their success stories. On this occasion, Vd. Rajesh Kotecha, Secretary of the Ministry of Ayush, said “Today we all have gathered here to brainstorm how we can collectively use the expertise and knowledge of the distinguished chair and set up the goal for the future. The pandemic allowed Ayush to develop their science, and Ayush did it by developing Ayush 64, etc.”. Pramod Kumar Pathak, Special Secretary, Ministry of Ayush, said “This meeting will help researchers to get the insights from Ayush Distinguished Chairs and know their experience in their field. An initiative like today’s was the need of the hour. The Ministry of Ayush is working to promote Ayush’s patents and research”. Welcoming everyone Prof. Tanuja Nesari, Director of AIIA said, “It is a historic movement when Administrators, Policy makers, Education experts, Researchers, and distinguished Scientists have come under one platform. This platform gives us an opportunity to create an evidence-based Ayurveda creating disciplinary model and integration. Prof. Vd Rabinarayan Acharya, Director General CCRAS, said “When we compare Ayush with Chinese alternative method of treatment, it has much more potential to go high. During COVID time Ayush system has registered more clinical studies, in comparison to the Chinese system of medicines. It is high time to give much priority to research,”. The meeting was attended by Heads of all Ayush National Institutions, Research, Councils, and advisors of MoA, Chairman of NCSIM Vaidya Jayant Deopujari, and NCH Dr. Anil Khurana including five newly- distinguished appointed scientists Ayush Distinguished Scientist Chairs Dr. Nandini K. Kumar (Interdisciplinary Clinical Research), Dr. Arvind Chopra, (Public health and Epidemiology), Dr. Sharmila Shekhar Mande (Ayurveda Biology and Basic Sciences), Dr. Madhu Dikshit (Pharmaceutical Drug Development) and Dr. B.N. Gangadhar (Consciousness and Cognitive Sciences). The meeting occurred in the August presence of Sec Ministry of Ayush Vd Rajesh Kotecha, Special Secretary P.K. Pathak, and Prof (Dr) Tanuja Nesari, Director, AIIA, Prof. (Vd.) Rabi Narayan Acharya, Director General (CCRAS) MDNIY Director Dr. Ishwar V. Basavaraddi and Prof. Bhushan Patwardhan, National Ayush Chairs, Directors of National Institute, and research councils. Read More►Journal of Research in Ayurvedic Sciences Focused on “Impact of Mann ki Baat on Ayush Sector”

All India Institute of Ayurveda (AIIA) under the Ministry of AYUSH hosted a walkthrough for the “Working Group of C20 on Integrated Holistic Health on 8th April 2023. A large group of over 400 delegates participated in the event and the institute showcased how an integrated approach to health care can be effectively implemented.. The C-20 is one of the eight official engagement groups of the G-20 forum. The 19 countries are Argentina, Australia, Brazil, Canada, China, Germany, France, India, Indonesia, Italy, Japan, Mexico, the Russian Federation, Saudi Arabia, South Africa, South Korea, Turkey, the UK, and the US which forms the C20 group. C20 India 2023 is one of the official Engagement Groups of the G20 that provides a platform for Civil Society Organizations (CSO) around the world to voice the people’s aspirations to the world leaders of G20. Dr. Anita Bhatia, Assistant Secretary-General of the United Nations and Deputy Executive Director of UN Women (for Resource Management, Sustainability, and Partnerships & United Nations Entity for Gender Equality and the Empowerment of Women); Swami Amritaswaroopananda Puri, Vice-Chairman of the Mata Amritanandamayi Math and President of Amrita Vishwa Vidyapeetham (Amrita University); Dr. Manoj Nesari, Adviser (Ay.), Ministry of Ayush; Dr. Adolpho Rubinstein, Former Health Minister of Argentina, Director of the Center for Implementation and Innovation in Health Policy. The founder and Director General of the Institute of Clinical Effectiveness and Health Policy (IECS) and others were the delegates who visited AIIA. The institute organized a walkthrough, where the delegates were taken to the hospital and highlighted how an integrated approach in health care can be effectively implemented for the well-being of humanity. AIIA has also signed an MoU with the University of Amrita Vishwa Vidhyapeetham for cooperation and collaboration in the field of Research and Academics in Ayurveda. Amrita Vishwa Vidyapeetham is a multi-campus, multi-disciplinary research academia university hereinafter referred to as Amrita. The MoU was signed by Prof. Tanuja Nesari, Director, AIIA, Ministry of Ayush, and Prem Kumar Vasudevan Nair, the Provost, of Medical Sciences at Kochi campus of Amrita Vishwa Vidhyapeetham. AIIA already has MoUs with the European Academy of Ayurveda, Bernstein, Germany; Western Sydney University, Australia; Graz Medical University, Austria; College of Medical, UK; London School of Hygiene & Tropical Medicine, UK and Federal University of Rio de Janeiro, Brazil. On this occasion Prof. (Dr) Tanuja Neasri, said “We are happy to co-host C20 delegates at AIIA, a tertiary care set-up under the Ministry of Ayush. We are honored to showcase the institute as a model of integration and holistic healthcare in Ayurveda. To help us realize the vision of health for all and holistic well-being, the strength of the Ayush system should be integrated into mainstream healthcare. “It is my pleasure to join you all at AIIA. The science of Ayurveda is India’s gift to the world - it is India’s knowledge, learning, tradition, and culture. Through C20, the focus is again being driven toward holistic healing through an integration of Ayurveda with modern medicine. This is an innovative approach and will benefit everyone,” said Dr. Ms. Anita Bhatia, Assistant Secretary-General UN & Deputy Executive Director, of UN Women. AIIA launched the millet calendar at the hands of Ms. Anita Bhatia, Assistant Secretary-General UN & Deputy Executive Director of UN Women. On the occasion AIIA received the blessings of Swamiji, Shri Amritaswaroopanand Puri. A cultural program followed by Patya Aahar was served to the guest on the occasion..  

धारगल (गोवा): प्रधानमंत्री नरेंद्र मोदी ने रविवार को विश्व आयुर्वेद कांग्रेस में अखिल भारतीय आयुर्वेद संस्थान के सेटेलाइट सेंटर का उद्घाटन किया, जिससे आयुर्वेदिक शिक्षा के लिए अवसरों का अनावरण हुआ और गोवा को चिकित्सा पर्यटन केंद्र के रूप में स्थापित किया गया। विश्व आयुर्वेद कांग्रेस में इस अवसर पर मोदी ने कहा कि अखिल भारतीय आयुर्वेद संस्थान भारत में चिकित्सा पर्यटन को बढ़ावा देने में महत्वपूर्ण भूमिका निभा सकता है। प्रधानमंत्री ने कहा, "सर्वे भवन्तु सुखिना, सर्वे संतु निरामय अर्थात सभी के लिए कल्याण की भावना भारत को चिकित्सा सुविधाएं प्रदान करने के क्षेत्र में आगे बढ़ने में मदद कर सकती है, विशेष रूप से आयुष क्षेत्र में, जो सभी के लिए अवसरों से भरा है। गोवा अंतर्राष्ट्रीय पर्यटन का केंद्र होने के कारण गोवा में अखिल भारतीय आयुर्वेद संस्थान के सेटेलाइट सेंटर की मदद से एक चिकित्सा पर्यटन केंद्र बनने की क्षमता रखता है।" "दुनिया के लिए, आयुर्वेद पारंपरिक चिकित्सा, कल्याण और समग्र उपचार के क्षेत्र में भारत की गहरी जड़ों को संप्रेषित करने का एक मजबूत माध्यम है। हमें अब दुनिया में आयुर्वेद की प्रभावशीलता को साबित करने के लिए डेटा-समर्थित साक्ष्यों पर काम करने की आवश्यकता है।" यह भी पढ़े► विश्व आयुर्वेद कांग्रेस और आरोग्य एक्सपो 2022 का उद्घाटन

A simple urine test can reveal if someone has early-stage Alzheimer's disease, potentially paving the way for an inexpensive and convenient disease screening. Researchers found that urinary formic acid is a sensitive marker of subjective cognitive decline that may indicate the very early stages of Alzheimer's disease. To reach this conclusion, the researchers tested a large group of patients with Alzheimer's disease of different levels of severity and healthy controls with normal cognition to identify differences in urinary biomarkers. Formic acid is a metabolic product of an organic compound formaldehyde. They found that urinary formic acid levels were significantly increased in all the Alzheimer's groups compared with the healthy controls, including the early-stage subjective cognitive decline group, and correlated with a cognitive decline. This suggests that formic acid could act as a sensitive biomarker for early-stage Alzheimer's disease, according to the study published in the journal Frontiers in Aging Neuroscience. "Alzheimer's disease is a continuous and concealed chronic disease, meaning that it can develop and last for many years before obvious cognitive impairment emerges," said the authors. "The early stages of the disease occur before the irreversible dementia stage, and this is the golden window for intervention and treatment. Therefore, large-scale screening for early-stage Alzheimer's disease is necessary for the elderly," they wrote. The current diagnostic techniques include positron emission tomography brain scans, which are expensive and expose the patient to radiation. There are also biomarker tests that can reveal Alzheimer's disease, but these require invasive blood draws or a lumbar puncture to obtain cerebrospinal fluid, which can be off-putting for patients. A total of 574 people participated in the study, and participants were either healthy volunteers with normal cognition, or had differing degrees of disease progression, ranging from subjective cognitive decline to fully-fledged disease. Interestingly, when the researchers analysed urinary formic levels in combination with blood-based Alzheimer's biomarkers, they found that they could more accurately predict what stage of the disease that a patient was experiencing. "Urinary formic acid showed an excellent sensitivity for early Alzheimer's screening," said the authors.